A COMPARISON OF PREMIXED INSULIN PREPARATIONS IN ELDERLY PATIENTS - EFFICACY OF 70/30 AND 50/50 HUMAN INSULIN MIXTURES

被引:9
|
作者
BRODOWS, R
CHESSOR, R
机构
[1] Nashville, TN 37211
关键词
D O I
10.2337/diacare.18.6.855
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To compare the postprandial hyperglycemic response to a standard breakfast of two premixed humulin insulin mixtures, 50/50 (50% NPH human insulin and 50% regular human insulin) and 70/30 (70% NPH human insulin and 30% regular human insulin) in elderly non-insulin-dependent diabetes mellitus (NIDDM) patients. RESEARCH DESIGN AND METHODS - On two mornings, each patient (n = 20) consumed a standard breakfast after a single dose of 50/50 or 70/30 insulin (0.3 U/kg) was administered in a randomized crossover fashion. Plasma glucose and serum free insulin concentrations were measured before and for 4 h after insulin administration. RESULTS - Plasma glucose reached a peak at 60 min and a nadir at 240 min for both types of insulin. No differences in maximum and minimum glucose concentrations, time to maximum and minimum glucose concentrations, or areas under the curve were noted. Free insulin levels did not differ significantly. CONCLUSIONS - These results suggest that small changes in the composition of premixed insulin mixtures in NIDDM patients may not result in improved postprandial glycemic control.
引用
收藏
页码:855 / 857
页数:3
相关论文
共 50 条
  • [1] Premixed 70/30 insulin aspart suspension improves insulin therapy related QOL in comparison with premixed 70/30 human insulin
    Yamada, S
    Tamada, T
    Suzuki, R
    Yajima, K
    Motohashi, Y
    Shimada, A
    [J]. DIABETES, 2005, 54 : A119 - A119
  • [2] Step-Up Treatment with Premixed Insulin Lispro-50/50 vs. Premixed Human Insulin Aspart-70/30: A Randomized Trial in Type 2 Diabetic Patients
    Ikeda, Shiori
    Monden, Tsuyoshi
    Matsumura, Mihoko
    Shimizu, Hiroaki
    Nakatani, Yuki
    Miyashita, Yasushi
    Domeki, Nozomi
    Yanagi, Kazunori
    Kasai, Kikuo
    [J]. DIABETES, 2010, 59 : A142 - A142
  • [3] Comparison of analog insulin mix 50:50 with human insulin mix 30:70 in persons with type 2 diabetes during Ramadan
    Hajjaji, Issam M.
    Eshwihdi, Naima
    Barrowman, Nick
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (06)
  • [4] Pharmacokinetic and pharmacodynamic differences between premixed suspensions of insulin aspart: biphasic insulin aspart 30, 50 and 70
    Heise, T
    Kapitza, C
    Jacobsen, LV
    Brondsted, L
    Heinemann, L
    [J]. DIABETOLOGIA, 2005, 48 : A301 - A301
  • [5] COST-MINIMIZATION ANALYSIS OF INSULIN LISPRO 50/50 VERSUS INSULIN ASPART 30/70 PREMIXED FORMULATIONS IN TYPE II DIABETES
    Yousefi, N.
    Taheri, S.
    Sheikhi, S.
    Amani, B.
    Akbarzadeh, A.
    Peiravian, F.
    [J]. VALUE IN HEALTH, 2019, 22 : S573 - S574
  • [6] Comparison of efficacy and safety between biphasic insulin aspart 50 and biphasic human insulin 50:A randomized crossover trial
    郭晓蕙
    [J]. China Medical Abstracts (Internal Medicine), 2016, 33 (04) : 204 - 205
  • [7] Premixed formulations of insulin Lispro:: Pharmacokinetic and pharmacodynamic properties of the 25:75 and the 50:50 mixtures
    Rave, K
    Nosek, L
    Roach, P
    De La Peña, A
    Bue-Valleskey, J
    Ristic, S
    Heinemann, L
    [J]. DIABETES, 2002, 51 : A112 - A112
  • [8] Efficacy of a New Protocol of Premixed 70/30 Human Insulin in Haitian Youth with Diabetes
    Jean-Baptiste, Eddy
    Larco, Philippe
    von Oettingen, Julia
    Ogle, Graham David
    Moise, Keddy
    Fleury-Milfort, Evelyne
    Paul, Rodolphe
    Charles, Rene
    Larco, Nancy Charles
    [J]. DIABETES THERAPY, 2021, 12 (09) : 2545 - 2556
  • [9] Efficacy of a New Protocol of Premixed 70/30 Human Insulin in Haitian Youth with Diabetes
    Eddy Jean-Baptiste
    Philippe Larco
    Julia von Oettingen
    Graham David Ogle
    Keddy Moïse
    Evelyne Fleury-Milfort
    Rodolphe Paul
    René Charles
    Nancy Charles Larco
    [J]. Diabetes Therapy, 2021, 12 : 2545 - 2556
  • [10] Glucodynamics and pharmacokinetics of 70/30 vs. 50/50 NPH/regular insulin mixtures after subcutaneous injection
    Krug, EI
    DeRiso, L
    Tedesco, MB
    Rao, H
    Korytkowski, MT
    [J]. DIABETES CARE, 2001, 24 (09) : 1694 - 1695